Studies have demonstrated KPV's ability to inhibit NF-κB activation in inflammatory cell models, examining the downstream reduction in pro-inflammatory cytokine production including TNF-α, IL-1β and IL-6.

Laboratory models have investigated KPV's effects on intestinal epithelial barrier function, measuring tight junction protein expression and transepithelial electrical resistance in models of gut permeability disruption.

Studies have examined KPV's anti-inflammatory effects in rodent models of inflammatory bowel disease, measuring histological inflammation scores, cytokine profiles and mucosal healing versus control groups.

Research has characterised KPV's effects on macrophage cytokine secretion, examining dose-dependent inhibition of LPS-stimulated TNF-α, IL-6 and IL-12 production in cell culture models.

Studies have investigated KPV's anti-inflammatory activity in cells lacking melanocortin receptors, confirming that its NF-κB inhibitory activity is at least partially independent of MC receptor engagement.

Laboratory research has examined KPV's anti-inflammatory effects in skin models, investigating its potential role in modulating inflammatory skin conditions at the cellular and cytokine level.

Allow vial to reach room temperature. Clean the rubber stopper with an alcohol swab and allow to dry completely.

Draw required volume of BAC water into a sterile syringe. Inject slowly down the inside of the vial wall — not directly onto the powder.

Gently swirl until powder fully dissolves. KPV dissolves almost instantly due to its small size. Solution should be clear and colourless.